The Effects of Colchicine on Lipoprotein(a) and Oxidized Phospholipid Associated Cardiovascular Disease Risk.

Autor: Mohammadnia N; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., van Broekhoven A; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands., Bax WA; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands., Eikelboom JW; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Mosterd A; Dutch Network for Cardiovascular Research (WCN), Utrecht, The Netherlands.; Department of Cardiology, Meander Medical Center, Amersfoort, The Netherlands., Fiolet ATL; Dutch Network for Cardiovascular Research (WCN), Utrecht, The Netherlands.; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., Tijssen JGP; Department of Cardiology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Thompson PL; Heart and Vascular Research Institute of Western Australia, Perth, Australia.; School of Medicine, University of Western Australia, Perth, Australia.; Sir Charles Gairdner Hospital, Perth, Australia., de Kleijn DPV; The Netherlands Heart Institute, Utrecht, The Netherlands.; Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands., Tsimikas S; Department of Medicine, University of California, San Diego, La Jolla, CA, USA., Cornel JH; Department of Cardiology, Northwest Clinics, Alkmaar, The Netherlands., Yeang C; Department of Medicine, University of California, San Diego, La Jolla, CA, USA., El Messaoudi S; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: European journal of preventive cardiology [Eur J Prev Cardiol] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.

High lipoprotein(a): Actionable strategies for risk assessment and mitigation.

Autor: Reyes-Soffer G; Department of Medicine, Columbia University Irving Medical Center, NY, USA., Yeang C; Department of Medicine, UC San Diego Health, CA, USA., Michos ED; Division of Cardiology, Johns Hopkins University School of Medicine, MD, USA., Boatwright W; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Ballantyne CM; Baylor College of Medicine, TX, USA.

Publikováno v: American journal of preventive cardiology [Am J Prev Cardiol] 2024 Apr 03; Vol. 18, pp. 100651. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).

Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease.

Autor: Rogers MA; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Bartoli-Leonard F; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Zheng KH; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Department of Vascular Medicine, Academic Medical Center, Amsterdam UMC, the Netherlands (K.H.Z., E.S.G.S.)., Small AM; Department of Medicine (A.M.S., C.J.O.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Boston VA Healthcare System, MA (A.M.S., P.N., C.J.O.)., Chen HY; Department of Medicine, McGill University, Montreal, Quebec, Canada (H.Y.C., J.C.E., G.T.)., Clift CL; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Asano T; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Kuraoka S; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Blaser MC; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Perez KA; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Natarajan P; Boston VA Healthcare System, MA (A.M.S., P.N., C.J.O.).; Cardiology Division, Department of Medicine, Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston (P.N.)., Yeang C; Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Department of Medicine, University of California, La Jolla, San Diego (C.Y., S.T.)., Stroes ESG; Department of Vascular Medicine, Academic Medical Center, Amsterdam UMC, the Netherlands (K.H.Z., E.S.G.S.)., Tsimikas S; Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Department of Medicine, University of California, La Jolla, San Diego (C.Y., S.T.)., Engert JC; Department of Medicine, McGill University, Montreal, Quebec, Canada (H.Y.C., J.C.E., G.T.)., Thanassoulis G; Department of Medicine, McGill University, Montreal, Quebec, Canada (H.Y.C., J.C.E., G.T.)., O'Donnell CJ; Department of Medicine (A.M.S., C.J.O.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Boston VA Healthcare System, MA (A.M.S., P.N., C.J.O.)., Aikawa M; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Center for Excellence in Vascular Biology (M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Singh SA; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Aikawa E; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Center for Excellence in Vascular Biology (M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Publikováno v: Circulation [Circulation] 2024 Jan 30; Vol. 149 (5), pp. 391-401. Date of Electronic Publication: 2023 Nov 08.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.